May 7, 2020 / 1:05 PM / a month ago

BRIEF-Sherlock Biosciences Received Emergency Use Authorization From FDA For Its Sherlock Crispr Sars-Cov-2 Kit

May 7 (Reuters) -

* SHERLOCK BIOSCIENCES - HAS RECEIVED EMERGENCY USE AUTHORIZATION FROM FDA FOR ITS SHERLOCK CRISPR SARS-COV-2 KIT Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below